Effect of oncotic pressure of diaspirin cross-linked hemoglobin (DCLHb(TM)) on brain injury after temporary focal cerebral ischemia in rats

被引:27
作者
Cole, DJ
Drummond, JC
Patel, PM
Nary, JC
Applegate, RL
机构
[1] UNIV CALIF SAN DIEGO,LA JOLLA,CA 92093
[2] VET ADM MED CTR,SAN DIEGO,CA 92161
关键词
D O I
10.1097/00000539-199608000-00024
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Previous studies have shown that diaspirin cross-linked hemoglobin (DCLHb(TM), 10 g/dL) decreases cerebral ischemia and the resultant injury in a dose-dependent manner, requiring large volumes of DCLHb(TM) for maximum efficacy. We assessed the effect of a more concentrated (20 g/dL) and more hyperoncotic preparation of DCLHb(TM) on cerebral infarction volume. Immediately after middle cerebral artery occlusion, rats were randomized to one of the following groups, Control, hematocrit not manipulated; 10/Hb, hematocrit decreased to 30% with 10% DCLHb(TM) (oncotic pressure 43 mm Hg); 7.5/Alb, hematocrit decreased to 30% with 7.5% albumin (oncotic pressure 43 mm Hg); 20/Hb, the same dose of DCLHb(TM) (20%, oncotic pressure 129 mm Hg) as the 10/Hb group (half the volume); or 15/Alb, the same dose of albumin (15%, oncotic pressure 130 mm Hg) as the 7.5/Alb group (half thr volume). After 90 min of ischemia, 72 h of reperfusion was allowed. Infarction volume (mm(3), mean +/- SD) was less in the DCLHb(TM) groups (10/Hb = 79 +/- 17; 20/Hb = 51 +/- 14) than the oncotically matched albumin groups (7.5/Alb = 124 +/- 21; 15/Alb = 85 +/- 18) and the Control group (135 +/- 17) (P < 0.05). These data indicate that in this model of cerebral ischemia, DCLHb(TM) decreases ischemic brain injury more effectively than albumin, and that a hyperoncotic preparation of DCLHb(TM) is preferable.
引用
收藏
页码:342 / 347
页数:6
相关论文
共 25 条
[1]   NITRIC-OXIDE BINDING TO HUMAN FERRIHEMOGLOBINS CROSS-LINKED BETWEEN EITHER ALPHA-SUBUNIT OR BETA-SUBUNIT [J].
ALAYASH, AI ;
FRATANTONI, JC ;
BONAVENTURA, C ;
BONAVENTURA, J ;
CASHON, RE .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 303 (02) :332-338
[2]  
ASHWAL S, 1993, J NEUROSURG ANESTH, V5, P241
[3]  
BAKER HJ, 1979, LABORATORY RAT, V1, P87
[4]   FUNDAMENTAL IMPORTANCE OF ARTERIAL OXYGEN-CONTENT IN THE REGULATION OF CEREBRAL BLOOD-FLOW IN MAN [J].
BROWN, MM ;
WADE, JPH ;
MARSHALL, J .
BRAIN, 1985, 108 (MAR) :81-93
[5]   FOCAL CEREBRAL-ISCHEMIA IN RATS - EFFECT OF HYPERVOLEMIC HEMODILUTION WITH DIASPIRIN CROSS-LINKED HEMOGLOBIN VERSUS ALBUMIN ON BRAIN INJURY AND EDEMA [J].
COLE, DJ ;
SCHELL, RM ;
DRUMMOND, JC ;
REYNOLDS, L .
ANESTHESIOLOGY, 1993, 78 (02) :335-342
[6]   HYPERVOLEMIC-HEMODILUTION AND HYPERTENSION DURING TEMPORARY MIDDLE CEREBRAL-ARTERY OCCLUSION IN RATS - THE EFFECT ON BLOOD-BRAIN-BARRIER PERMEABILITY [J].
COLE, DJ ;
DRUMMOND, JC ;
MATSUMURA, JS ;
MARCANTONIO, S ;
CHILUM, BI .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1990, 17 (04) :372-377
[7]   EFFECTS OF VISCOSITY AND OXYGEN-CONTENT ON CEREBRAL BLOOD-FLOW IN ISCHEMIC AND NORMAL RAT-BRAIN [J].
COLE, DJ ;
DRUMMOND, JC ;
PATEL, PM ;
MARCANTONIO, S .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1994, 124 (01) :15-20
[8]   FOCAL CEREBRAL-ISCHEMIA IN RATS - EFFECT OF HEMODILUTION WITH ALPHA-ALPHA CROSS-LINKED HEMOGLOBIN ON CBF [J].
COLE, DJ ;
SCHELL, RM ;
PRZYBELSKI, RJ ;
DRUMMOND, JC ;
BRADLEY, K .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1992, 12 (06) :971-976
[9]   CUSTOM-TAILORED HEMODILUTION WITH ALBUMIN AND CRYSTALLOIDS IN ACUTE ISCHEMIC STROKE [J].
GOSLINGA, H ;
EIJZENBACH, V ;
HEUVELMANS, JHA ;
DEVRIES, EV ;
MELIS, VMJ ;
SCHMIDSCHONBEIN, H ;
BEZEMER, PD .
STROKE, 1992, 23 (02) :181-188
[10]   LONG-TERM HIGH-COLLOID ONCOTIC THERAPY FOR ISCHEMIC BRAIN EDEMA IN GERBILS [J].
HAKAMATA, Y ;
ITO, U ;
HANYU, S ;
YOSHIDA, M .
STROKE, 1995, 26 (11) :2149-2153